| | Class 2 Device Recall Portex Pulsator Arterial Blood Sampling Kit with Liquid Sodium Heparin |  |
| Date Initiated by Firm | June 22, 2018 |
| Create Date | February 15, 2019 |
| Recall Status1 |
Terminated 3 on October 05, 2020 |
| Recall Number | Z-0843-2019 |
| Recall Event ID |
80829 |
| 510(K)Number | K952516 |
| Product Classification |
Tubes, vials, systems, serum separators, blood collection - Product Code JKA
|
| Product | Aplicare Povidone Iodine Prep Pads packaged within Portex Pulsator Arterial Blood Sampling Kit with Liquid Sodium Heparin, models 4037NP-1, 4039-1, 4039EG-1, 4044EG-1, 4044P-1, 4057NP-1, 4067NP-1, 4077EG-1, 4077NP-1, 4084P-1, G1193, G1374, G1585, G1589, G1598, G1621, and G1806. The firm name on the label is Smiths Medical ASD, Inc., Keene, NH. |
| Code Information |
Product with expiration dates between 11/30/2016 and 5/31/2020. |
| FEI Number |
3012307300
|
Recalling Firm/ Manufacturer |
Smiths Medical ASD Inc. 6000 Nathan Ln N Minneapolis MN 55442-1690
|
Manufacturer Reason for Recall | The povidone iodine prep pads packaged with the arterial blood sampling kits will not maintain the iodine potency through its labeled 36-month expiration dating. |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | The recalling firm issued letters via UPS tracked mail on 6/22/2018 and later again to additional customers on 7/19/2018. An amended letter was issued on 9/20/2018 via UPS tracked mail to include some model numbers that were inadvertently omitted in the previous letter issuance. |
| Quantity in Commerce | Approx. 28,578,939 kits for both products |
| Distribution | Distribution was nationwide, including Puerto Rico. There was also military/government distribution. Foreign distribution was made to Canada, United Arab Emirates, Bahamas, Costa Rica, Latvia, and Saudi Arabia. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = JKA
|
|
|
|